HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of increased cyclic adenosine 3':5'-monophosphate content in cultured human breast cancer cells and release of hydrolytic enzymes and bone-resorbing activity.

Abstract
The established human breast cancer cell line MCF-7 resorbs bone directly in vitro independently of viable endogenous bone cells, and this resorption of bone is closely correlated with the release of hydrolytic enzymes by the cultured tumor cells. In this study we have examined the effects of a number of drugs which increase the intracellular cyclic adenosine 3':5'-monophosphate (cyclic AMP) content on the release of hydrolytic enzymes by the tumor cells and their capacity to resorb bone. When MCF-7 cultures were treated with cholera toxin (0.05 to 5 micrograms/ml), a potent adenylate cyclase inducer, mineral-releasing, lysosomal enzyme, and collagenolytic activities increased more than 2-fold in the cell culture medium. Prostaglandin E1 (0.1 microM), 8-bromocyclic AMP (10 mM), and isobutylmethylxanthine (30 microM) caused similar effects. These data suggest that adenylate cyclase activation and increases in cyclic AMP content in the tumor cells caused the release of lysosomal enzymes and collagenolytic activity and caused the resorption of bone. We have previously found that colchicine, a drug which inhibits microtubule assembly, also increased hydrolytic enzyme release and release of bone-resorbing activity. Direct measurements of cyclic AMP were made in MCF-7 cells 3 hr after treatment with colchicine (10 microM) as well as MCF-7 cells treated with prostaglandin E1, cholera toxin, and isobutylmethylxanthine. MCF-7 cells showed a 2-fold increase in cyclic AMP content after treatment with all of these agents, although there was no similar increase in mouse 3T3 cells which do not produce bone-resorbing activity under these conditions. These data suggest that increases in cyclic AMP concentrations in human breast cancer cells lead to release of hydrolytic enzymes and resorption of bone.
AuthorsG Eilon, G R Mundy
JournalCancer research (Cancer Res) Vol. 43 Issue 12 Pt 1 Pg. 5792-4 (Dec 1983) ISSN: 0008-5472 [Print] United States
PMID6196108 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Prostaglandins E
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Cholera Toxin
  • Cyclic AMP
  • Hydrolases
  • Alprostadil
  • Colchicine
  • Calcium
  • 1-Methyl-3-isobutylxanthine
Topics
  • 1-Methyl-3-isobutylxanthine (pharmacology)
  • 8-Bromo Cyclic Adenosine Monophosphate (pharmacology)
  • Alprostadil
  • Bone Resorption (drug effects)
  • Breast Neoplasms (physiopathology)
  • Calcium (metabolism)
  • Cell Line
  • Cholera Toxin (pharmacology)
  • Colchicine (pharmacology)
  • Cyclic AMP (metabolism)
  • Female
  • Humans
  • Hydrolases (metabolism)
  • Kinetics
  • Prostaglandins E (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: